Five-drug combination targets aggressive B-cell lymphomas

1 year ago 27
More than half of trial participants treated with venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) had substantial tumor shrinkage.
Read Entire Article